Targeted cancer drug RAF Kinase Inhibitor licensing press conference(105.02.18)
• UBIP licensed from DCB a new targeted cancer drug
UBIP pre-listing presentation (105.01.21)

Chairperson Dr. Chang Yi Wang’s speech at the Emerging Stock board pre-listing presentation